Summary A hospital-based case-control study was undertaken to examine the role of human papillomavirus (HPV) (e.g. HPV 6, 11, 42, 43, 44) have been associated with condylomata acuminata and CIN I (Howley, 1991; Lorincz et al., 1992) .
Epidemiological investigations have shown consistently that measures of sexual behaviour, such as number of sexual partners and early age at first intercourse, are major determinants of cervical neoplasia (Franco, 1991) , suggesting a sexually transmitted agent as a likely cause. Impressive experimental data have been accumulated to support an aetiological role for human papillomavirus (HPV) in the pathogenesis of anogenital cancer, especially cervical cancer (Howley, 1991; zur Hausen, 1991) . Sixty-seven different types of HPV have now been described, and 28 have been isolated from benign and malignant genital lesions (de Villiers, 1992) . These viruses have been further classified according to their supposed malignant potential. 'High-risk' types (e.g. HPV 16, 18, 31, 33, 35, 51, 52) have been linked to cervical intraepithelial neoplasia (CIN) II and III and invasive cervical cancer, whereas 'low-risk' types (e.g. HPV 6, 11, 42, 43, 44) have been associated with condylomata acuminata and CIN I (Howley, 1991; Lorincz et al., 1992) .
Epidemiological studies investigating the relation between HPV and cervical neoplasia have found strong associations . However, some of these studies are difficult to interpret because of methodological flaws in study design (Munoz et al., 1988) or because of the inaccuracy of the hybridisation techniques used to detect HPV DNA (Schiffman, 1992) . Recently a reliable and sensitive HPV detection strategy based on the polymerase chain reaction (PCR) has been developed in several laboratories (Manos et al., 1989; van den Brule et al., 1990) and is now considered the technique of choice for epidemiological studies (Schiffman, 1992) . Employing this technique, two recent studies have found high risks of cervical cancer associated with HPV (Peng et al., 1991; Munoz et al., 1992) .
In developing countries cancer of the cervix is the leading cancer even when sites common to both sexes are combined (Parkin et al., 1988) . This hospital-based case-control study using PCR was undertaken to examine the role of HPV in the development of invasive cervical cancer in Sao Paulo, Brazil, a city with one of the highest incidence rates of this disease worldwide (Muir et al., 1987) .
Patients and methods

Study population
Between June 1990 and June 1991 women with a diagnosis of invasive cervical cancer and women selected as controls were recruited from seven hospitals in Sao Paulo City. Five of these are general hospitals, and two are hospitals for the treatment of cancer. The cases were women between 25 and 79 years of age, whose diagnosis was confirmed by histopathology and who had had no previous treatment for the disease. Controls were enrolled from the same five general hospitals from which the cases were recruited. For cases from the hospitals in which only cancer patients are treated (n = 48), controls were selected from the largest general hospital included in the study. This was because had the cancer cases had another disease it is likely that they would have been treated there as it is the most commonly used referral hospital in the city. Controls were frequency matched to cases in 5-year age groups. Those with diseases associated with known risk factors for cervical neoplasia were excluded (sexually transmitted diseases, coronary heart disease, cerebrovascular disease, arterial thromboembolism, thrombophlebitis, chronic bronchitis, emphysema, neoplasia of the breast, reproductive and respiratory organs, anus, oral cavity, (Walboomers et al., 1992) . Briefly, a first screening to determine the overall presence of HPV was performed using general primers GP 5/6 in the PCR, which permits the detection of the sequenced genital HPV types 6, 11, 16, 18, 31 and 33 but also detects still unsequenced genital HPV types at the subpicogram level (Snijders et al., 1990) . After low-stringency Southern blot analysis with probes of HPV-specific PCR products, the GP-PCR-positive scrapes were subjected to TS-PCR to establish the specific type of HPV present. Mixtures of HPV 6, 16, 33 and HPV 11, 18, 31 specific primer sets (van den Brule et al., 1989; Walboomers et al., 1992) were used to detect the sequenced HPV genotypes.
TS-PCR products were identified by size determination and by Southern blot analysis using internal oligonucleotide probes. Scrapes that were positive by GP-PCR and negative by TS-PCR were suspected of containing still unidentified HPV genotypes. Special precautions taken to minimise falsepositive results in the PCR have been described in detail elsewhere . To analyse the quality of target DNA for PCR purposes, scrapes were subjected to PCR using P-globin gene-specific primers. When this target of the P-globin gene was successfully amplified it indicated that the DNA was suitable for PCR analysis.
Statistical analysis
To estimate the risk of cervical cancer associated with selected factors, odds ratios (OR) and 95% confidence intervals (95% CI) were calculated as approximations of relative risks using unconditional logistic regression analysis (Breslow & Day, 1980) . Potential confounding variables and interactions with the factors of interest were examined using this method. Statistical significance was assessed using the likelihood ratio test (Breslow & Day, 1980) . Tests for trend were made by categorising the exposure variables and entering the scores as continuous. As measures of socioeconomic status, income per capita and number of household facilities showed the strongest association with risk of cervical cancer. When the variables of interest were adjusted by either of these measures, the results were very similar. Since more than 12% of women did not know the family income, and as data on household facilities were complete, the latter was chosen as the indicator for socioeconomic status. All odds ratios were adjusted for age in 5-year groups (25-29, 30-34, ... 75-79 years) and for socioeconomic status in four categories (having four, three, two and one or no household facilities). Parity was defined as number of live and still births. Sixtyfive cases (32.7%) and 49 controls (22.5%) were not living in Sao Paulo in the 12 months before the interview. When the data were examined by place of residence, the risk estimates associated with the main variables of interest were of similar magnitude. The odds ratios were not, therefore, adjusted for place of residence.
Results
The mean age of both cases and controls was similar, being 52.1 years and 52.4 years respectively. There was, however, a difference in the socioeconomic status of cases and controls. Compared with those having four household facilities, the age-adjusted odds ratios associated with having three, two and one or no household facilities were 1.6 (95% CI 1.0-2.7), 2.3 (95% CI 1.2-4.4) and 3.1 (95% CI 1.6-6.1) respectively [X2 (trend) (Table I) .
Cases and controls who reported having had two or more sexual partners had a higher prevalence of HPV DNA (Table  I) (HPV 16/18/ 31/33) , almost 66% of the cases were positive compared with only 6% of the controls. The odds ratio of cervical cancer associated with these types was 75.1 (95% CI 34.2-165.0) (Table III) . Table IV shows the risks associated with each of the factors found to have been significantly related to cervical cancer risk after adjustment for age, socioeconomic status and all the other factors in the table. Only detection of HPV DNA, number of Pap smears and parity remained independently associated with risk of cervical cancer. The risks associated with the HPV types investigated remained almost unchanged from those shown in Table III . Table V shows the interactions of HPV detection with smoking habits and duration of oral contraceptive use. Although there appears to be a stronger effect of smoking in the HPV-negative stratum, the term for interaction was not significant (P = 0.18). The use of oral contraceptives for 5 or more years was associated with a higher risk in the HPVpositive stratum. However, in this stratum the use of oral contraceptives for a shorter period was not associated with an increased risk of cervical cancer when compared with never-users (the odds ratio was even lower). Therefore, the term for interaction had a large P value (0.81). Although there was no significant interaction between HPV detection 
Discussion
This is the first case-control study of invasive cervical cancer ever reported from Brazil. We found that 84% of cervical cancer cases had HPV DNA in their cervical smears as detected by PCR. This is similar to the prevalence found in a French study (84%) (Riou et al., 1990) and in an Australian study (80%) (Higgins et al., 1991) , in which cervical carcinoma specimens were obtained by biopsy or surgical excision. It (Schiffman, 1992) . (Schiffman, 1992) . (Ley et al., 1991) . That in the current study no statistically significant association was found, despite using PCR, may be because only 33% of the women in this control group reported having had more than one sexual partner compared with 81% of those in their investigation. Kjaer et al., 1993) . Another explanation could be the partners' sexual behaviour. The 'male factor' will be addressed in a future report. Increasing number of regular partners tended to be associated with higher HPV prevalence, mainly among cases, whereas no association at all was found with increasing number of casual partners. It could be conceived that to acquire and have persistent infection frequent contacts with an infected partner would be usually needed. However, as the natural history of HPV infection is only just beginning to be understood, this is merely speculation. Another possibility could be that there is more chance of misclassification for number of casual partners than for number of regular partners.
We found presence of HPV DNA, early age at first intercourse, increasing number of sexual partners, increasing parity and increasing duration of oral contraceptive use to be significantly related to an increased risk and number of Pap smears to be significantly related to a decreased risk of cervical cancer. However, in a multivariate analysis in which all the variables were adjusted for each other as well as for age and socioeconomic status, only HPV DNA, number of Pap smears and parity remained as independent risk factors. While the efficacy of cytological screening has never been evaluated by a randomised trial, many studies have found evidence of protection against the development of cervical cancer (Day, 1989) . It should be emphasised that in this study misclassification of Pap smear history should have been minimised as questions were included to help women distinguish between the taking of smears and other gynaecological procedures. In some previous studies the association found between increased parity and cancer of the cervix was ascribed to the association with sexual behaviour. However, two recent investigations have demonstrated an independent effect (Brinton et al., 1989; Parazzini et al., 1989) . The risk of cervical cancer associated with presence of the 'high-risk' HPV types 16/18/31/33 was 69.7 (95% CI 28.7-169.6). Risks of such magnitude are rarely found in epidemiological studies, being even higher than those found with hepatitis B virus for hepatocellular carcinoma (Trichopoulos et al., 1987) . A large case-control study conducted in various Latin American countries has found a relative risk of 2.1 (95% CI 1.6-2.8) associated with low signal intensity and 9.1 (95% CI 6.1-13.6) with high signal intensity for HPV 16/18 using filter in situ hybridisation (Reeves et al., 1989) . However, this assay is now considered as the least accurate hybridisation test for the detection of HPV DNA (Schiffman, 1992) . Three studies, in which the PCR technique was used, also found high risks for cervical neoplasia associated with HPV (Morrison et al., 1991; Peng et al., 1991; Munoz et al., 1992) . In China, the risk of invasive cervical cancer associated with HPV types 16/33 was 32.9 (95% CI 7.7-141.1) (Peng et al., 1991) . In a population-based case-control study of invasive cervical cancer the risk related to any type of HPV DNA was 15.6 (95% CI 6.9-34.7) in Colombia and 46.2 (95% CI 18.5-115.1) in Spain . Results from a case-control study conducted in the USA have shown a risk of 7.2 (95% CI 2.4-21.9) for cervical squamous intraepithelial lesions associated with one HPV type and 43.0 (95% CI 6.9-266.6) associated with more than one type (Morrison et al., 1991) .
It has been postulated that smoking (Herrero et al., 1989 ) and oral contraceptive use might interact with HPV in the aetiology of cervical cancer. In this study there was no evidence of interaction between HPV and smoking. Nor was there a statistically significant interaction between HPV and duration of oral contraceptive use, a finding that was demonstrated in the study from Colombia and Spain ). An increased risk associated with HPV infection was found among women who used oral contraceptives for longer periods. Although this finding could be due to chance, it is in agreement with oral contraceptives acting as a promoter for other risk factor(s), in this circumstance HPV. Nevertheless, some investigators suggest that the role of exogenous mutagenic factors may have been overemphasised previously (zur Hausen, 1991) .
It should be pointed out that the small number of HPVpositive controls (32) and of HPV-negative cases (29) limits the possibility of detecting statistically significant interactions between HPV and the other risk factors for cervical cancer. This lack of power has also been a limitation of other studies. Specially designed case-control studies matched on HPV status might increase the power.
With a case-control design one cannot be sure whether the HPV infection preceded or post-dated the disease. In addition, it might be easier to detect HPV in infected cancer cells rather than in infected non-malignant cells. So far, only a few small follow-up studies have been published with results that have no clear interpretation . However, a recent follow-up study of 241 women with normal cytology has found a relative risk of 11 (95% CI 4.6-26) for the development of CINII-III related to infection with HPV 16/18 (Koutsky et al., 1992) .
Our study had limitations in that it was hospital based and not restricted to women with permanent residence in Sao Paulo. However, we selected controls with a wide range of diagnoses, the risks estimates associated with the main variables of interest were similar when examined by place of residence, 98% of our cases had their biopsies read by a single experienced pathologist, cases were restricted to invasive stages and extreme care was employed during sample preparation and in the PCR analysis to avoid contamination. Furthermore, risks of this magnitude can hardly be explained by the limitations outlined above. The experimental evidence for the malignant potential of HPV and the very high risks found in this study, particularly in relation to HPV types 16, 18, 31 and 33, further implicates this virus in the aetiology of cervical cancer.
